Synthesis and biological evaluation of a novel MUC1 glycopeptide conjugate vaccine candidate comprising a 4’-deoxy-4’-fluoro-Thomsen–Friedenreich epitope
The development of selective anticancer vaccines that provide enhanced protection against tumor recurrence and metastasis has been the subject of intense research in the scientific community. The tumor-associated glycoprotein MUC1 represents a well-established target for cancer immunotherapy and has...
Main Authors: | Manuel Johannes, Maximilian Reindl, Bastian Gerlitzki, Edgar Schmitt, Anja Hoffmann-Röder |
---|---|
Format: | Article |
Language: | English |
Published: |
Beilstein-Institut
2015-01-01
|
Series: | Beilstein Journal of Organic Chemistry |
Subjects: | |
Online Access: | https://doi.org/10.3762/bjoc.11.15 |
Similar Items
-
Prognostic significance of muc4 expression in gallbladder carcinoma
by: Lee Hyeon, et al.
Published: (2012-10-01) -
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
by: Md Kamal Hossain, et al.
Published: (2016-07-01) -
Associations between the expression of mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas
by: Onur Oral, et al.
Published: (2020-01-01) -
Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy
by: Dapeng Zhou, et al.
Published: (2018-05-01) -
Airway Mucus and Asthma: The Role of MUC5AC and MUC5B
by: Luke R. Bonser, et al.
Published: (2017-11-01)